Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis p53'

Search results for: 'research area apoptosis p53'

Items 11-20 of 31

Page
per page
  1. Lenalidomide (CC-5013)
    A4211 Lenalidomide (CC-5013)
    Target: angiogenesis
    Summary: Antineoplastic agent,inhibits angiogenesis
      insoluble in EtOH; insoluble in H2O; ≥100.8 mg/mL
  2. Pomalidomide (CC-4047)
    A4212 Pomalidomide (CC-4047)
    Summary: Immunomodulator,antumor/anti-angiogenic
      insoluble in EtOH; insoluble in H2O; ≥7.5 mg/mL
  3. MIM1
    A4465 MIM1
     1 Citation
    Target: Mcl-1
    Summary: Mcl-1 Inhibitor
      insoluble in EtOH; insoluble in H2O; ≥12.15 mg/mL
  4. CID 755673
    A8678 CID 755673
    Target: PKD
    Summary: PKD inhibitor
  5. ABT-199
    A8194 ABT-199
     14 Citation
    Target: Bcl-2
    Summary: Bcl-2 inhibitor,potent and selective
      ≥43.42 mg/mL
  6. ABT-263 (Navitoclax)
    A3007 ABT-263 (Navitoclax)
     15 Citation
    Target: Bcl-2|Bcl-w
    Summary: Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w
      ≥48.73 mg/mL
  7. AMG232
    A8804 AMG232
     2 Citation
    Target: p53-MDM2 interaction
    Summary: p53-MDM2 inhibitor, novel
      Soluble in DMSO
  8. HA14-1
    A8168 HA14-1
    Target: Bcl-2
    Summary: Bcl-2 inhibitor,potent and cell-permeable
      insoluble in H2O; ≥20.45 mg/mL
  9. WEHI-539
    A3935 WEHI-539
     15 Citation
    Target: Bcl-xl
    Summary: Bcl-xL inhibitor,potent and selective
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  10. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL

Items 11-20 of 31

Page
per page